AUSCANN GROUP S Share · AU000000AC89 · A2DLBP (XASX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AUSCANN GROUP S
No Price
Company Profile for AUSCANN GROUP S Share
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Company Data
Name AUSCANN GROUP S
Company AusCann Group Holdings Ltd
Website
https://auscann.com.au
Primary Exchange 
ASX
ASX
WKN A2DLBP
ISIN AU000000AC89
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Christopher Mews B. Bus,
Country Australia
Currency EUR
Employees 0,0 T
Address 35 Havelock Street, 6005 West Perth
IPO Date 2017-02-10
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ACNNF |
More Shares
Investors who hold AUSCANN GROUP S also have the following shares in their portfolio:
